> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CDER/CBER Add 84 Employees in Fourth Quarter
- URL: https://www.fdaweb.com/cder-cber-add-84-employees-in-fourth-quarter/
- Published: 2026-11-05T21:58:00.000Z
- Updated: 2026-11-06T02:58:26.000Z
- Author: David McFarland
- Tags: Drugs, Biologics

FDA's drug and biologics review centers added a net 84 employees during the fourth quarter of fiscal year 2026, reversing earlier staffing losses but leaving their combined workforce about 18% below its level at the beginning of fiscal 2025, according to newly updated agency hiring data.

The [figures](https://www.fda.gov/industry/fda-user-fee-programs/center-drug-evaluation-and-research-center-biologics-evaluation-and-research-net-hiring-data-fy-2023?ref=fdaweb.com) show that the CDER gained 137 employees and lost 71 during the quarter ending 9/30, leading to a net gain of 66\. CBER gained 43 employees and lost 25, for a net increase of 18\. For the full fiscal year, CDER recorded a net gain of 10 employees, while CBER lost 36, producing a combined net reduction of 26.

The results follow much larger reductions in fiscal 2025, when CDER lost a net 1,093 employees and CBER lost 224\. Combined staffing at the two centers declined from 7,417 at the beginning of fiscal 2025 to 6,074 at the end of fiscal 2026, a reduction of 1,343 employees, or 18.1%.